Patents by Inventor Romana Hochreiter

Romana Hochreiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING THREE OSPA FUSION PROTEINS FOR MEDICAL USE
    Publication number: 20230173051
    Abstract: The present invention relates to a composition comprising the OspA fusion protein of SEQ ID NO: 1 (LipSID1-S2D1), the OspA fusion protein of SEQ ID NO: 2 (Lip-S4D1-SShybD1) and the OspA fusion protein of SEQ ID NO: 3 (Lip-S5D1-S6D1) for use in a vaccine or for use in a method for eliciting an immune response in a human against Lyme disease.
    Type: Application
    Filed: April 9, 2021
    Publication date: June 8, 2023
    Applicants: Valneva Austria GmbH, Pfizer Inc.
    Inventors: Nicole Bézay, Romana Hochreiter, Urban Lundberb, Steven Russell Bailey, Annaliesa Sybil Anderson, Kathrin Ute Jansen, Daniel Alfred Scott
  • SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE
    Publication number: 20220313810
    Abstract: The present invention relates to a single-shot live attenuated vaccine against Chikungunya virus which is well-tolerated and induces long-lasting protective immunity in adult human subjects.
    Type: Application
    Filed: August 10, 2020
    Publication date: October 6, 2022
    Applicant: Valneva SE
    Inventors: Nina Wressnigg, Romana Hochreiter